Journal Reports: Investing Monthly
AARP-Branded Medicare Drug Plan Is Too Costly for Many Retirees, Critics Say
By R, andall Smith
November 4, 2022 at 2:00 PM ET
The popular plan’s price has risen sharply in recent years—prompting some experts to suggest enrollees consider switching.